Related Experiment Video
Updated: Jan 13, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Nutritional Status, Body Composition and Growth in Paediatric-Onset Ulcerative Colitis: A Systematic Review
Chen Sarbagili-Shabat1, Floor Timmer1, Konstantina Morogianni2
1Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, 1105 AZ Amsterdam, The Netherlands.
Insights
Pediatric ulcerative colitis (UC) can lead to growth impairment and poor nutritional status in children and adolescents. More research is needed to fully understand UC
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Nutritional Science in Pediatrics
Background:
- Growth impairment and poor nutritional status are known complications of pediatric inflammatory bowel disease (IBD).
- Specific data on ulcerative colitis (UC), a subset of IBD, are limited.
- Understanding these issues in pediatric UC is crucial for effective management.
Purpose of the Study:
- To systematically review and synthesize current knowledge on growth, nutritional status, and body composition in pediatric patients with UC.
- To identify gaps in the existing literature regarding UC's impact on these parameters.
- To inform future research directions.
Main Methods:
- A systematic literature search was conducted up to August 2025.
- Studies involving patients aged 5-22 years with confirmed UC were included.
- Findings on growth, nutrition, and body composition were narratively synthesized.
Main Results:
- Fifteen studies (1575 patients) met the criteria, with data often derived from broader IBD cohorts.
- Growth failure affected 7-36% of patients, with weight deficits more prevalent than height deficits.
- Undernutrition was observed in up to 25% of patients; body composition data were limited and inconsistent.
Conclusions:
- Growth impairment and poor nutritional status are potential issues in pediatric UC.
- Current data are limited by sample size and heterogeneity.
- Larger, standardized studies specifically on UC, including body composition, are necessary.
Abstract:
Background: Growth impairment and poor nutritional status are recognized complications of pediatric inflammatory bowel disease (IBD), yet data specific to ulcerative colitis (UC) are limited. This systematic review aims to provide an overview of current knowledge on growth, nutritional status, and body composition in children and adolescents with UC. Methods: A systematic literature search was performed up to August 2025. Studies including patients aged 5-22 years with confirmed UC were reviewed. Results related to growth, nutritional status, and body composition were narratively synthesized to summarize findings. Results: Fifteen studies with 1575 patients with UC met inclusion criteria, comprising 5 prospective, 5 cross-sectional, and 5 retrospective designs. Although the included studies were conducted in broader IBD cohorts, only UC-specific outcomes were reported. The data were limited by sample size, heterogeneity in patient characteristics, outcome definitions, and assessment methods. The majority of patients had prolonged disease with remission or mild activity. Growth failure prevalence ranged from 7% to 36%, with weight deficits being more common than height deficits. Undernutrition affected up to 25% of patients, with variability across studies. Overweight and obesity were also observed, though most studies showed no significant differences between UC patients and controls. Only five very small studies assessed body composition, reporting inconsistent findings regarding reductions in lean body mass. Conclusions: Growth impairment and poor nutritional status can occur in children and adolescents with UC. Larger, standardized, high-quality studies focused specifically on UC are needed to better characterize its impact on growth and nutritional status, including the essential integration of body composition assessment.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

